ANICHINI, GABRIELE
 Distribuzione geografica
Continente #
EU - Europa 1.136
NA - Nord America 590
AS - Asia 182
AF - Africa 18
OC - Oceania 7
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 1.939
Nazione #
US - Stati Uniti d'America 587
IT - Italia 348
IE - Irlanda 312
RU - Federazione Russa 117
SE - Svezia 96
GB - Regno Unito 69
SG - Singapore 58
FI - Finlandia 56
FR - Francia 50
DE - Germania 46
CN - Cina 36
IN - India 18
VN - Vietnam 16
BE - Belgio 9
BD - Bangladesh 8
CI - Costa d'Avorio 8
IQ - Iraq 8
HK - Hong Kong 7
ES - Italia 6
GH - Ghana 6
SA - Arabia Saudita 6
AU - Australia 5
CZ - Repubblica Ceca 5
TH - Thailandia 5
BR - Brasile 4
MT - Malta 4
AT - Austria 3
NL - Olanda 3
PK - Pakistan 3
RO - Romania 3
TR - Turchia 3
UA - Ucraina 3
BG - Bulgaria 2
CA - Canada 2
CH - Svizzera 2
EU - Europa 2
IL - Israele 2
IR - Iran 2
KR - Corea 2
NZ - Nuova Zelanda 2
PH - Filippine 2
ZA - Sudafrica 2
AL - Albania 1
EG - Egitto 1
GE - Georgia 1
ID - Indonesia 1
JP - Giappone 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MA - Marocco 1
PA - Panama 1
Totale 1.939
Città #
Dublin 304
Chandler 125
Siena 115
Ashburn 57
Southend 52
Helsinki 49
Fairfield 46
Singapore 44
Princeton 35
Florence 33
New York 28
Wilmington 27
Rome 24
Munich 19
Houston 18
Woodbridge 17
Seattle 16
Cambridge 15
Dong Ket 14
Fremont 12
Abidjan 8
Milan 8
Ann Arbor 7
Shanghai 7
Brussels 6
Chittagong 6
Hong Kong 6
Messina 6
Moscow 6
Málaga 6
San Diego 6
San Mateo 6
Malappuram 5
Poli 5
Accra 4
Boardman 4
Botanic Ridge 4
Cagliari 4
Campofilone 4
Columbus 4
Karbala 4
Khobar 4
La Spezia 4
Lappeenranta 4
Livorno 4
Marano Di Napoli 4
Pescara 4
Pontedera 4
Washington 4
Bangkok 3
Espoo 3
London 3
Los Angeles 3
Modena 3
Norwalk 3
Paris 3
Pelotas 3
Prato 3
San Francisco 3
Vienna 3
Auckland 2
Barletta 2
Bengaluru 2
Cebu City 2
Cheltenham 2
Chennai 2
Chicago 2
Cortona 2
Dammam 2
Duino-Aurisina 2
Duisburg 2
Empoli 2
Frankfurt am Main 2
Galveston 2
Gyeongju 2
Hanover 2
Hounslow 2
Istanbul 2
Jacksonville 2
Kirkuk 2
Leawood 2
Lucca 2
Meherpur 2
Menlo Park 2
Milton Keynes 2
Olomouc 2
Oxford 2
Pisa 2
Port Elizabeth 2
Ratchathewi 2
Santa Clara 2
Santa Maria a Monte 2
Tel Aviv 2
Trieste 2
Zanjan 2
Altamura 1
Andover 1
Anguillara Sabazia 1
Bagnacavallo 1
Beijing 1
Totale 1.306
Nome #
Immune response analysis to Measles virus in subjects vaccinated with MMR vaccine and naturally infected subjects. 208
Whole-Genome Sequence of SARS-CoV-2 Isolate Siena-1/2020 145
Antibody response to SARS-CoV-2 in infected patients with different clinical outcome 124
Seroprevalence to measles virus after vaccination or natural infection in an adult population, in Italy 111
Overview of Anti-SARS-CoV-2 Immune Response Six Months after BNT162b2 mRNA Vaccine 106
Ubiquitin and not only unfolded domains drives toscana virus non-structural NSs protein degradation 99
Toscana virus non-structural protein NSs acts as E3 ubiquitin ligase promoting RIG-I degradation 94
How long can SARS-CoV-2 persist in human corpses? 83
Identification of a neutralizing epitope on tosv gn glycoprotein 82
SARS-CoV-2 Antibody Response in Persons with Past Natural Infection 78
Infectious Toscana virus in seminal fluid of young man returning from Elba Island, Italy 78
Residual SARS-CoV-2 RNA in nasal swabs of convalescent COVID-19 patients: Is prolonged quarantine always justified? 75
Detection of asymptomatic SARS-CoV-2 infections among healthcare workers: Results from a large-scale screening program based on rapid serological testing 74
Neutralizing antibody response of vaccinees to SARS-CoV-2 variants 70
Human Polymorphonuclear Cells Support Zika Virus to Cross Endothelial Monolayer and Access Bloodstream 66
Rational Use of Monoclonal Antibodies as Therapeutic Treatment in an Oncologic Patient with Long COVID 61
Efficient inactivation of sars-cov-2 and other rna or dna viruses with blue led light 60
Omicron infection evokes cross-protection against SARS-CoV-2 variants in vaccinees 59
Hyperimmune plasma in three immuno-deficient patients affected by non-severe, prolonged COVID-19: a single-center experience 59
Comparative performance of a new sars-cov-2 rapid detection system 59
SARS-CoV-2 infection in cancer patients on active therapy after the booster dose of mRNA vaccines 54
SARS-CoV-2 n protein targets TRIM25-mediated RIG-I activation to suppress innate immunity 35
Nucleopore Traffic Is Hindered by SARS-CoV-2 ORF6 Protein to Efficiently Suppress IFN-β and IL-6 Secretion 33
SARS-CoV-2 omicron sub-lineages differentially modulate interferon response in human lung epithelial cells 29
Dysregulation of intracellular redox homeostasis by the SARS-CoV-2 ORF6 protein 28
Antibody Response against Circulating Omicron Variants 8 Months after the Third Dose of mRNA Vaccine 28
Deletion of 82–85 N-Terminal Residues in SARS-CoV-2 Nsp1 Restricts Virus Replication 27
SARS-CoV-2 JN.1 variant evasion of IGHV3-53/3-66 B cell germlines 14
Totale 2.039
Categoria #
all - tutte 10.667
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.667


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021266 0 0 0 15 12 62 42 22 22 24 16 51
2021/2022277 9 10 10 16 5 13 8 20 63 19 37 67
2022/2023474 24 59 53 44 40 94 9 59 48 13 22 9
2023/2024658 12 39 57 37 33 124 204 19 7 32 28 66
2024/2025364 57 55 118 91 43 0 0 0 0 0 0 0
Totale 2.039